{"id":"W2092480028","doi":"10.1186/1741-7015-10-161","title":"Clinical development of phosphatidylinositol 3-kinase inhibitors for cancer treatment","year":2012,"lang":"en","type":"review","venue":"BMC Medicine","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":92,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Sociedad Española de Oncología Médica; Conquer Cancer Foundation","keywords":"Crizotinib; Medicine; PI3K/AKT/mTOR pathway; Anaplastic lymphoma kinase; Cancer research; Receptor tyrosine kinase; Kinase; Tyrosine kinase; Clinical trial; Cancer; Gene isoform; Pharmacology; Signal transduction; Oncology; Biology; Lung cancer; Internal medicine; Receptor; Cell biology; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005971264,0.0007859272,0.001196538,0.001443721,0.0001853326,0.0007222886,0.0009086949,0.001001813,0.004712828],"category_scores_gemma":[0.0005337259,0.0002444243,0.0004592122,0.001124599,0.0002859742,0.0007944711,0.000541526,0.00179698,0.003774667],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004590194,"about_ca_system_score_gemma":0.0006078398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004392842,"about_ca_topic_score_gemma":0.001231937,"domain_scores_codex":[0.9998131,0.00003526593,0.00001973301,0.00003084612,0.00008336233,0.0000177331],"domain_scores_gemma":[0.9998471,0.00005015832,0.00002626297,0.000005607475,0.00005210509,0.00001889268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001223189,0.0001007238,0.00009999418,0.006289823,0.00007167912,0.0001727614,0.00002532947,0.0002812154,0.003831462,0.001921322,0.02205938,0.9650239],"study_design_scores_gemma":[0.0001110073,0.0002195968,0.0006965785,0.001442267,0.0001005104,0.001127483,0.00001994,0.0001372176,0.001486117,0.001094457,0.9935493,0.00001565751],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004117868,0.9953739,0.0004338299,0.0003817983,0.0002942946,0.00002515134,0.00005374977,0.00002148729,0.003003946],"genre_scores_gemma":[0.002368798,0.9935241,0.0006999242,0.0005478423,0.000212869,0.00003596,0.0001498572,0.000005889138,0.00245473],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004712828,"threshold_uncertainty_score":0.01576596,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.171878412395407,"score_gpt":0.4533208998068582,"score_spread":0.2814424874114513,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}